Dofequidar
目录号: A22042
sphingomyelin synthase 抑制剂
Dofequidar(也被称为 MS-209)是一种衍生自喹诺酮的鞘磷脂合成酶抑制剂,它能阻断P-糖蛋白和多药耐药相关蛋白-1,目前由Schering公司开发,用于潜在治疗多药耐药性肿瘤。
Discription | Dofequidar, also known as MS-209, is a quinolone-derived sphingomyelin synthase inhibitor that blocks P-glycoprotein and multidrug resistance-associated protein-1, is under development by Schering for the potential treatment of multidrug resistant tumors. |
---|
目录号 | A22042 |
---|---|
分子式 | C30H31N3O3 |
分子量 | 481.59 |
CAS号 | 129716-58-1 |
SMILES | OC(COC1=C2C=CC=NC2=CC=C1)CN3CCN(C(C(C4=CC=CC=C4)C5=CC=CC=C5)=O)CC3 |
其他名称 | MS-209; MS 209; MS209 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2